All Posts: Georgetown Lombardi
-
Identifying ‘Stealth’ Sources of Saturated Fat, Added Sugar in the Diet
A newly compiled list of foods and drinks commonly consumed in the United States hints at why many adults unknowingly overdo it on saturated fat and added sugar in their daily diet, a new study by a team including Georgetown Lombardi researchers suggests.
Category: GUMC Stories
-
ISPY2: A Unique, Flexible Breast Cancer Trial for Modern Times
The ISPY2 breast cancer clinical trial is a unique phase 2 study that offers a broad range of treatment options for patients with locally advanced breast cancer.
Category: GUMC Stories
-
Georgetown Global Health and Cancer Researchers Tackle Public Health Challenge in Eswatini
A collaboration between researchers at Georgetown’s Lombardi Comprehensive Cancer Center and a Georgetown global health team in Eswatini aims to address a significant public health challenge: preventing cervical cancer.
Category: GUMC Stories
-
At 36th Annual Lombardi Gala, Friends Help Push Boundaries
A community of nearly 500 new and longtime friends donned gowns and black ties for the 36th annual Lombardi Gala, the largest continuous fundraising event for Georgetown’s Lombardi Comprehensive Cancer Center.
Category: GUMC Stories
-
Georgetown’s Cancer Center Awarded Top Designation by Federal Government
The National Cancer Institute (NCI), a part of the National Institutes of Health, has awarded its most prestigious designation — “comprehensive cancer center” status — to Georgetown University‘s Lombardi Comprehensive Cancer Center in recognition of its high-impact research, community outreach and cancer care. Georgetown Lombardi is the only such center in the Washington area.
Category: News Release
-
The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA.
Category: News Release
-
Psychosocial Oncology Program Promotes Cura Personalis in Cancer Care
As director of the psychosocial oncology program at Georgetown Lombardi, Kimberly M. Davis, PhD, supports the psychological needs of cancer patients, while also training future independent clinical researchers in the field.
Category: GUMC Stories
-
New Georgetown Lombardi Office Cultivates Diversity, Equity and Inclusion at the Cancer Center
Despite significant advances in cancer prevention, screening, diagnosis and treatment over the last several decades, persistent cancer health disparities disproportionately impact populations who have been historically underrepresented in science and medicine. Diversity in cancer research and education is a critical part of changing that paradigm. And critical to achieving that is cultivating an inclusive environment at work — the goal of the new Office of Diversity, Equity and Inclusion at Georgetown Lombardi.
Category: GUMC Stories
-
Could a Georgetown Lab Finding Lead to New Treatment in Pancreatic Cancer?
For the first time, new research by Georgetown scientists shows potential to make immunotherapy effective in pancreatic cancer by combining it with a drug that makes cancer cells more responsive to immunotherapy.
Category: GUMC Stories
-
Staying Hands-on in Hope: For the Future of Pediatric Cancer Research (and Maybe a New Car)
The Hyundai Hands On Hope contest, generously sponsored by the Washington Area Hyundai Dealers, ran January 19 to 21 and featured healthy competition between Georgetown Lombardi and Children’s National.
Category: GUMC Stories